<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/144"/><api:result><api:object category="publication" id="144" last-affected-when="2023-12-24T20:53:02.29+00:00" last-modified-when="2023-12-24T20:53:02.29+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/144" created-when="2010-05-17T13:46:12.053+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-11-29</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="2449164" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.2165/00019053-199303050-00006" last-modified-when="2022-09-11T03:14:40.573+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>Ben A</api:first-names><api:separate-first-names><api:first-name>Ben</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wielink</api:last-name><api:initials>G</api:initials><api:first-names>Gina</api:first-names><api:separate-first-names><api:first-name>Gina</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonsel</api:last-name><api:initials>GJ</api:initials><api:first-names>Gouke J</api:first-names><api:separate-first-names><api:first-name>Gouke</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rutten</api:last-name><api:initials>FFH</api:initials><api:first-names>Frans FH</api:first-names><api:separate-first-names><api:first-name>Frans</api:first-name><api:first-name>F</api:first-name><api:first-name>H</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-199303050-00006</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-199303050-00006"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-199303050-00006"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>387</api:begin-page><api:end-page>397</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1993</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.2165/00019053-199303050-00006</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>20</api:day><api:month>1</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of ACE Inhibitors on Heart Failure in The Netherlands</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>3</api:text></api:field></api:native></api:record><api:record format="native" id="131438" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0027601077" last-modified-when="2023-11-21T22:41:08.673+00:00"><api:citation-count>50</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Summary A modelling approach is uscd to analyse the cost effectiveness of prescribing angiotensin converting enzyme (ACE) inhibitors, compared with standard practice, as first-line therapeutic agents in the treatment of hean failure in The Netherlands. Data concerning costs, incidence. prevalence and survival are used to construct an age-dependent semi-Markov-chain model. Two scenarios are compared. The first reflects the continuation of common practice. The second. containing assumptions made on the basis of results from randomised clinical trials, reflects the situation in which ACE inhibitors are given as first-lin e pharmacotherapy. Conditional on the esti mates and assumptions made. it is shown that prescribing ACE inhibitors as first-tine pharmacotherapy will improve survival by about 4% over the first 10 years. and will save about 17% in costs over the first 10 years. Sensiti vity analysis shows the robustness of the conclusio ns to all major parameters. Â© 1993, Adis International Limited. All rights reserved.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Hour</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57018183100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wielink</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602592381</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bonsel</api:last-name><api:initials>GJ</api:initials><api:first-names>GJ</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55947154000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rutten</api:last-name><api:initials>FFH</api:initials><api:first-names>FFH</api:first-names><api:separate-first-names><api:first-name>F</api:first-name><api:first-name>F</api:first-name><api:first-name>H</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005090997</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-199303050-00006</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-199303050-00006"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-199303050-00006"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10146889</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>387</api:begin-page><api:end-page>397</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1993</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of ACE Inhibitors on Heart Failure in The Netherlands: A Pharmacoeconomic Model</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>3</api:text></api:field></api:native></api:record><api:record format="native" id="144" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10146889" last-modified-when="2022-11-22T21:16:34.197+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A modelling approach is used to analyse the cost effectiveness of prescribing angiotensin converting enzyme (ACE) inhibitors, compared with standard practice, as first-line therapeutic agents in the treatment of heart failure in The Netherlands. Data concerning costs, incidence, prevalence and survival are used to construct an age-dependent semi-Markov-chain model. Two scenarios are compared. The first reflects the continuation of common practice. The second, containing assumptions made on the basis of results from randomised clinical trials, reflects the situation in which ACE inhibitors are given as first-line pharmacotherapy. Conditional on the estimates and assumptions made, it is shown that prescribing ACE inhibitors as first-line pharmacotherapy will improve survival by about 4% over the first 10 years, and will save about 17% in costs over the first 10 years. Sensitivity analysis shows the robustness of the conclusions to all major parameters.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="full">Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Wielink</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonsel</api:last-name><api:initials>GJ</api:initials><api:first-names>GJ</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rutten</api:last-name><api:initials>FF</api:initials><api:first-names>FF</api:first-names><api:separate-first-names><api:first-name>F</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10146889</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-199303050-00006</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-199303050-00006"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-199303050-00006"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pharmacoeconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh">Drug Prescriptions</api:keyword><api:keyword scheme="mesh">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh">Heart Failure</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>New Zealand</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>387</api:begin-page><api:end-page>397</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1993</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>25</api:day><api:month>8</api:month><api:year>1994</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>3</api:text></api:field></api:native></api:record><api:record format="native" id="858378" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10146889" last-modified-when="2020-06-10T00:42:59.63+01:00"><api:citation-count>25</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A modelling approach is used to analyse the cost effectiveness of prescribing angiotensin converting enzyme (ACE) inhibitors, compared with standard practice, as first-line therapeutic agents in the treatment of heart failure in The Netherlands. Data concerning costs, incidence, prevalence and survival are used to construct an age-dependent semi-Markov-chain model.  Two scenarios are compared.  The first reflects the continuation of common practice.  The second, containing assumptions made on the basis of results from randomised clinical trials, reflects the situation in which ACE inhibitors are given as first-line pharmacotherapy.  Conditional on the estimates and assumptions made, it is shown that prescribing ACE inhibitors as first-line pharmacotherapy will improve survival by about 4% over the first 10 years, and will save about 17% in costs over the first 10 years.  Sensitivity analysis shows the robustness of the conclusions to all major parameters.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="NL"><api:line type="full">Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wielink</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonsel</api:last-name><api:initials>GJ</api:initials><api:first-names>GJ</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rutten</api:last-name><api:initials>FF</api:initials><api:first-names>FF</api:first-names><api:separate-first-names><api:first-name>F</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-199303050-00006</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-199303050-00006"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-199303050-00006"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1179-2027</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10146889</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Heart Failure</api:keyword><api:keyword scheme="mesh">Drug Prescriptions</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>387</api:begin-page><api:end-page>397</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1993</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>8</api:day><api:month>4</api:month><api:year>1993</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>3</api:text></api:field></api:native></api:record><api:record format="native" id="3083591" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1039078588" last-modified-when="2023-12-24T20:53:02.293+00:00"><api:citation-count>37</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>6</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Hour</api:last-name><api:initials>BA</api:initials><api:first-names>Ben A</api:first-names><api:separate-first-names><api:first-name>Ben</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Wielink</api:last-name><api:initials>G</api:initials><api:first-names>Gina</api:first-names><api:separate-first-names><api:first-name>Gina</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01354143716.49</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bonsel</api:last-name><api:initials>GJ</api:initials><api:first-names>Gouke J</api:first-names><api:separate-first-names><api:first-name>Gouke</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01241633666.33</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rutten</api:last-name><api:initials>FFH</api:initials><api:first-names>Frans FH</api:first-names><api:separate-first-names><api:first-name>Frans</api:first-name><api:first-name>F</api:first-name><api:first-name>H</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01174260760.93</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.2165/00019053-199303050-00006</api:text><api:links><api:link type="doi" href="http://doi.org/10.2165/00019053-199303050-00006"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.2165/00019053-199303050-00006"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10146889</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1170-7690</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PharmacoEconomics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Cardiovascular</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh">Drug Prescriptions</api:keyword><api:keyword scheme="mesh">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh">Heart Failure</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>11</api:month><api:year>2012</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>387</api:begin-page><api:end-page>397</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>1993</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>1.11</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of ACE Inhibitors on Heart Failure in The Netherlands</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>3</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Drug Prescriptions</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Heart Failure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Heart Failure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Drug Prescriptions</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Angiotensin-Converting Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Costs and Cost Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Drug Prescriptions</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Economics, Pharmaceutical</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Heart Failure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Treatment Outcome</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">14 Economics</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Health Policy &amp; Services</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3801 Applied economics</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4203 Health services and systems</api:keyword></api:keywords></api:all-labels><api:journal issn="1170-7690" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973037" title="PharmacoEconomics (Auckland)"><api:records><api:record source-name="summary"><api:title>PharmacoEconomics (Auckland)</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/144/relationships"/></api:object></api:result></api:response>